Randeep Sangha Selected Research

Randeep Sangha Research Topics

Disease

15	Neoplasms (Cancer) 07/2022 - 10/2004
13	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2020 - 08/2007
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 06/2015
4	Exanthema (Rash) 01/2022 - 08/2011
3	Lung Neoplasms (Lung Cancer) 04/2021 - 09/2009
3	Febrile Neutropenia 01/2017 - 12/2011
2	Fatigue 10/2019 - 12/2014
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2017 - 06/2015
2	Adenocarcinoma 01/2015 - 10/2004
2	Diarrhea 12/2014 - 12/2011
2	Neoplasm Metastasis (Metastasis) 01/2010 - 09/2009
1	Disease Progression 01/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Death (Near-Death Experience) 01/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	follicular Thyroid cancer 09/2019
1	Thyroid Neoplasms (Thyroid Cancer) 09/2019
1	Follicular Adenocarcinoma 09/2019
1	Cachexia 04/2019
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2017
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 06/2015
1	Neutropenia 06/2015
1	Gastroesophageal Reflux (GERD) 01/2015
1	Stomatitis 12/2014
1	Infections 12/2011
1	Mucositis 12/2011
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 09/2009
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2009
1	Prostatic Neoplasms (Prostate Cancer) 11/2007
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2004

Drug/Important Bio-Agent (IBA)

4	Rituximab (Mabthera)FDA Link 10/2017 - 06/2015
3	Tyrosine Kinase InhibitorsIBA 09/2019 - 12/2009
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2015 - 12/2009
3	ErbB Receptors (EGF Receptor)IBA 12/2011 - 03/2009
2	NivolumabIBA 01/2022 - 01/2019
2	Pemetrexed (MTA)FDA Link 01/2022 - 12/2014
2	IpilimumabIBA 01/2022 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2020 - 12/2014
2	Carboplatin (JM8)FDA LinkGeneric 10/2019 - 04/2019
2	Gemcitabine FDA Link 01/2017 - 10/2004
2	Docetaxel (Taxotere)FDA Link 12/2011 - 12/2009
2	L-BLP25IBA 11/2007 - 08/2007
2	Glycoproteins (Glycoprotein)IBA 11/2007 - 08/2007
2	Protein Subunit VaccinesIBA 11/2007 - 08/2007
1	Prescription DrugsIBA 07/2022
1	CrizotinibIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 04/2021
1	Anaplastic Lymphoma KinaseIBA 09/2020
1	lorlatinibIBA 09/2020
1	enfortumab vedotinIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	Phosphotransferases (Kinase)IBA 09/2019
1	IodineIBA 09/2019
1	regorafenibIBA 09/2019
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 09/2019
1	Sorafenib (BAY 43-9006)FDA Link 09/2019
1	lenvatinibIBA 09/2019
1	atezolizumabIBA 07/2019
1	obinutuzumabIBA 10/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017
1	Inotuzumab OzogamicinIBA 01/2017
1	Guanosine Diphosphate (GDP)IBA 01/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	polatuzumab vedotinIBA 06/2015
1	Immunoconjugates (Immunoconjugate)IBA 06/2015
1	AfatinibIBA 12/2014
1	Cetuximab (Erbitux)FDA Link 08/2011
1	DNA (Deoxyribonucleic Acid)IBA 12/2009
1	PlatinumIBA 03/2009
1	Growth Factor ReceptorsIBA 03/2009
1	Monoclonal AntibodiesIBA 03/2009
1	AntigensIBA 11/2007
1	Cancer VaccinesIBA 11/2007
1	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 10/2004
1	Equilibrative Nucleoside Transporter 1IBA 10/2004

Therapy/Procedure

13	Therapeutics 01/2022 - 08/2007
11	Drug Therapy (Chemotherapy) 01/2022 - 10/2004
1	Transplantation 01/2022
1	Radiotherapy 06/2017
1	Adjuvant Chemotherapy 01/2010
1	Chemoradiotherapy 08/2007